This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Bial Industrial Farmaceutica, S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations in Allergy Treatment: The Work of Iñaki Ibarrola Lopez De Davalillo
Introduction
Iñaki Ibarrola Lopez De Davalillo is an innovative inventor based in Bilbao, Spain. His work focuses on addressing allergies, specifically those triggered by mites. With a keen eye for scientific advancements, he has made significant contributions to the field of immunology through his patented invention.
Latest Patents
Ibarrola Lopez De Davalillo holds one patent titled "Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies." This patent describes recombinant DNA molecules that code for hybrid polypeptides made from fragments of allergens Derp p 1 and Derp p 2. These proteins exhibit hypoallergenic characteristics while retaining their immunogenic capacity, making them particularly useful in the prevention and treatment of mite allergies. Additionally, the patent details efficient production and purification methods for these hybrid proteins, paving the way for advancements in allergy treatment.
Career Highlights
Currently, Iñaki Ibarrola Lopez De Davalillo is affiliated with Bial Industrial Farmaceutica, S.A., a company dedicated to developing innovative pharmaceutical solutions. His role in advancing medical knowledge and applications demonstrates his commitment to improving patients' lives through scientific exploration and innovation.
Collaborations
During his career, Ibarrola Lopez De Davalillo has collaborated with notable colleagues, including Juan Andrés Asturias Ortega and Maria Carmen Arilla Rodriguez. These partnerships have undoubtedly contributed to the research and development of effective allergy treatments, reinforcing the importance of teamwork in the scientific community.
Conclusion
Iñaki Ibarrola Lopez De Davalillo is a distinguished inventor whose work continues to impact allergy treatment significantly. Through his innovative patent and collaborations with skilled professionals, he is paving the way for a future where allergies caused by mites can be effectively managed and treated. His contributions are a testament to the importance of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile